Αποτελέσματα Αναζήτησης
Conduct Review of New Drug Application (NDA) or Biologics License Application (BLA) The review process takes place in six major steps.
- FDA's Drug Review Process: Continued
Vertical Format: Click here for a high-resolution, printable...
- FDA's Drug Review Process: Continued
The table below lists all official FDA Guidance Documents and other regulatory guidance. You can search for documents using key words, and you can narrow or filter your results by product,...
Vertical Format: Click here for a high-resolution, printable PDF (3.9 MB) of the infographic. Drug Review Steps Simplified. Preclinical (animal) testing. An investigational new drug...
This document provides guidance to industry and the review staff in the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) on good review management principles and practices (GRMPs) for the conduct of the first cycle
12 Μαρ 2004 · This guidance applies to manufacturers of drug products (finished pharmaceuticals), including products regulated by the Center for Biologics Evaluation and Research (CBER), the Center for...
What is the approval process for biosimilar products? All FDA-approved biological products, including reference products and biosimilar products, undergo a rigorous evaluation so that patients...
Guidance documents listed below represent the agency's current thinking on the conduct of clinical trials, good clinical practice and human subject protection. Guidance documents are not...